gallick
- 03 Feb 2004 23:05
IP2IPO is a recent float, at the back end of last year (Oct 15, 2003). It is an intellectual property business that commercializes modern technology rights. Ipo has a series of contracts with top universities such as Oxford, York and Southampton. It is mainly involved in scientific intellectual property (IP), such as gene research. They develop long term relationships with the Universities of 15 to 25 years.
The objective is to licence IP, or make money from the equity from the companies that they spin off. Already they have spun off HepCgen in whom they have a 24% stake. HepCgen have signed contracts with major pharmaceutical companies to provide diagnostic tests for detecting Hepatitis C in patients.
The venture capital companies have taken a serious interest in IPO, perhaps because they understand them better than most. Also Evolution Group (supposedly one of the hottest smaller co brokers around) have taken a 40 % stake in them. Right now they seem to be going into vertical lift-off mode. I suspect there will be further announcements in due course. Could be worth a dabble but, as always, dyor.
irlee57
- 11 Jul 2012 10:41
- 9 of 9
can any of you learned gentlemen help, i have a small holding in ipo, can any one explain to me the constant selling of 19/20 shares every 3 minutes it seems such an insignificant amount,